Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Propylthiouracil treatment can cause hair loss.

Valproic acid and isoniazid can interact, causing toxicity, so careful monitoring is needed.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Midazolam's seizure prevention is partly due to increased neurosteroid production.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib might be used to treat hair loss.

The combination of encorafenib and binimetinib caused few skin issues.

A girl's hair loss from a pharmacy error improved after getting the right medicine.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Minoxidil can make it hard to detect cocaine in hair tests.

Lamotrigine can cause hair loss.

Sodium metabisulfite increases sodium channel activity, leading to higher cell excitability and potential damage.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Minoxidil metabolizes similarly in monkeys and humans, but differently in dogs and rats.